Fordyce Marshall, President and CEO of Vera Therapeutics, Inc. ($VERA), sold shares once on the open market in the last 365 days for a total of $711 thousand. His most recent sale occurred on February 23, 2026. These sales rank 5,703rd among 11,678 individual insiders, where the average sale amount is 8.6 million and the average number of transactions is 6.4. Fordyce Marshall made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 23, 2026 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | S | Class A Common Stock | 16925 | $41.98 | 479,193.0000 | 63,928,066 | 3.41% | 0.03% |
| Feb. 4, 2026 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | A | Stock Option (right to buy) | 137500 | $0.00 | 137,500.0000 | 63,928,066 | 9999.99% | 0.22% |
| Feb. 4, 2026 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | A | Class A Common Stock | 68800 | $0.00 | 496,118.0000 | 63,928,066 | 16.10% | 0.11% |
| Feb. 26, 2025 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | S | Class A Common Stock | 1100 | $28.32 | 426,695.0000 | 63,748,290 | 0.26% | 0.00% |
| Feb. 21, 2025 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | S | Class A Common Stock | 10613 | $27.89 | 435,770.0000 | 0 | 2.38% | 0.00% |
| Feb. 26, 2025 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | S | Class A Common Stock | 7975 | $27.55 | 427,795.0000 | 63,748,290 | 1.83% | 0.01% |
| Feb. 18, 2025 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | A | Class A Common Stock | 80750 | $0.00 | 446,383.0000 | 0 | 22.08% | 0.00% |
| Feb. 18, 2025 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | A | Stock Option (right to buy) | 161500 | $0.00 | 161,500.0000 | 0 | 9999.99% | 0.00% |
| Jan. 8, 2025 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | M | Class A Common Stock | 1875 | $2.90 | 367,508.0000 | 0 | 0.51% | 0.00% |
| Jan. 8, 2025 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | M | Stock Option (Right to Buy) | 15625 | $0.00 | 610,926.0000 | 0 | 2.49% | 0.00% |
| Jan. 8, 2025 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | M | Stock Option (Right to Buy) | 1875 | $0.00 | 609,051.0000 | 0 | 0.31% | 0.00% |
| Jan. 8, 2025 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | M | Class A Common Stock | 9975 | $2.90 | 375,608.0000 | 0 | 2.73% | 0.00% |
| Jan. 8, 2025 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | S | Class A Common Stock | 9975 | $41.53 | 365,633.0000 | 0 | 2.66% | 0.00% |
| Jan. 8, 2025 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | M | Class A Common Stock | 5650 | $2.90 | 371,283.0000 | 0 | 1.55% | 0.00% |
| Jan. 8, 2025 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | S | Class A Common Stock | 5650 | $42.03 | 365,633.0000 | 0 | 1.52% | 0.00% |
| Jan. 8, 2025 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | S | Class A Common Stock | 1875 | $42.00 | 365,633.0000 | 0 | 0.51% | 0.00% |
| Dec. 19, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | M | Class A Common Stock | 57661 | $2.90 | 365,633.0000 | 0 | 18.72% | 0.00% |
| Dec. 18, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | M | Class A Common Stock | 3772 | $2.90 | 311,744.0000 | 0 | 1.22% | 0.00% |
| Dec. 18, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | S | Class A Common Stock | 3772 | $41.33 | 307,972.0000 | 0 | 1.21% | 0.00% |
| Dec. 18, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | M | Class A Common Stock | 2195 | $2.90 | 310,167.0000 | 0 | 0.71% | 0.00% |
| Dec. 18, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | S | Class A Common Stock | 2195 | $42.35 | 307,972.0000 | 0 | 0.71% | 0.00% |
| Dec. 18, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | M | Class A Common Stock | 5023 | $2.90 | 312,995.0000 | 0 | 1.63% | 0.00% |
| Dec. 18, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | S | Class A Common Stock | 5023 | $43.52 | 307,972.0000 | 0 | 1.60% | 0.00% |
| Dec. 18, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | M | Class A Common Stock | 4635 | $2.90 | 312,607.0000 | 0 | 1.51% | 0.00% |
| Dec. 18, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | S | Class A Common Stock | 4635 | $44.03 | 307,972.0000 | 0 | 1.48% | 0.00% |
| Dec. 18, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | M | Class A Common Stock | 1875 | $2.90 | 309,847.0000 | 0 | 0.61% | 0.00% |
| Dec. 18, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | S | Class A Common Stock | 1875 | $43.81 | 307,972.0000 | 0 | 0.61% | 0.00% |
| Dec. 18, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | M | Stock Option (Right to Buy) | 15625 | $0.00 | 686,087.0000 | 0 | 2.23% | 0.00% |
| Dec. 18, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | M | Stock Option (Right to Buy) | 1875 | $0.00 | 684,212.0000 | 0 | 0.27% | 0.00% |
| Dec. 19, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | M | Stock Option (Right to Buy) | 57661 | $0.00 | 626,551.0000 | 0 | 8.43% | 0.00% |
| Dec. 11, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | S | Class A Common Stock | 700 | $47.55 | 307,972.0000 | 0 | 0.23% | 0.00% |
| Dec. 11, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | M | Class A Common Stock | 1775 | $2.90 | 309,747.0000 | 0 | 0.58% | 0.00% |
| Dec. 11, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | S | Class A Common Stock | 1775 | $46.94 | 307,972.0000 | 0 | 0.57% | 0.00% |
| Dec. 11, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | M | Class A Common Stock | 100 | $2.90 | 308,072.0000 | 0 | 0.03% | 0.00% |
| Dec. 11, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | S | Class A Common Stock | 100 | $47.65 | 307,972.0000 | 0 | 0.03% | 0.00% |
| Dec. 11, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | M | Stock Option (Right to Buy) | 15625 | $0.00 | 703,587.0000 | 0 | 2.17% | 0.00% |
| Dec. 11, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | M | Stock Option (Right to Buy) | 1875 | $0.00 | 701,712.0000 | 0 | 0.27% | 0.00% |
| Dec. 11, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | M | Class A Common Stock | 700 | $2.90 | 308,672.0000 | 0 | 0.23% | 0.00% |
| Dec. 11, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | S | Class A Common Stock | 14925 | $46.91 | 307,972.0000 | 0 | 4.62% | 0.00% |
| Dec. 11, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | M | Class A Common Stock | 14925 | $2.90 | 322,897.0000 | 0 | 4.85% | 0.00% |
| Nov. 25, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | S | Class A Common Stock | 7665 | $48.18 | 307,972.0000 | 0 | 2.43% | 0.00% |
| Nov. 25, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | M | Class A Common Stock | 1381 | $2.90 | 309,353.0000 | 0 | 0.45% | 0.00% |
| Nov. 25, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | S | Class A Common Stock | 1381 | $48.80 | 307,972.0000 | 0 | 0.45% | 0.00% |
| Nov. 25, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | M | Class A Common Stock | 1875 | $2.90 | 309,847.0000 | 0 | 0.61% | 0.00% |
| Nov. 25, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | S | Class A Common Stock | 1875 | $48.76 | 307,972.0000 | 0 | 0.61% | 0.00% |
| Nov. 25, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | M | Class A Common Stock | 1875 | $2.90 | 309,847.0000 | 0 | 0.61% | 0.00% |
| Nov. 25, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | S | Class A Common Stock | 1875 | $49.00 | 307,972.0000 | 0 | 0.61% | 0.00% |
| Nov. 25, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | M | Stock Option (Right to Buy) | 15625 | $0.00 | 722,962.0000 | 0 | 2.12% | 0.00% |
| Nov. 25, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | M | Stock Option (Right to Buy) | 1875 | $0.00 | 721,087.0000 | 0 | 0.26% | 0.00% |
| Nov. 25, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | M | Stock Option (Right to Buy) | 1875 | $0.00 | 719,212.0000 | 0 | 0.26% | 0.00% |
| Nov. 25, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | M | Class A Common Stock | 6579 | $2.90 | 314,551.0000 | 0 | 2.14% | 0.00% |
| Nov. 25, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | S | Class A Common Stock | 6579 | $47.05 | 307,972.0000 | 0 | 2.09% | 0.00% |
| Nov. 25, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | M | Class A Common Stock | 7665 | $2.90 | 315,637.0000 | 0 | 2.49% | 0.00% |
| Nov. 13, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | M | Class A Common Stock | 100 | $2.90 | 308,072.0000 | 0 | 0.03% | 0.00% |
| Nov. 13, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | M | Class A Common Stock | 12218 | $2.90 | 320,190.0000 | 0 | 3.97% | 0.00% |
| Nov. 13, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | S | Class A Common Stock | 12218 | $49.54 | 307,972.0000 | 0 | 3.82% | 0.00% |
| Nov. 13, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | M | Class A Common Stock | 3307 | $2.90 | 311,279.0000 | 0 | 1.07% | 0.00% |
| Nov. 13, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | S | Class A Common Stock | 3307 | $50.28 | 307,972.0000 | 0 | 1.06% | 0.00% |
| Nov. 13, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | S | Class A Common Stock | 100 | $51.20 | 307,972.0000 | 0 | 0.03% | 0.00% |
| Nov. 13, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | M | Class A Common Stock | 1565 | $2.90 | 309,537.0000 | 0 | 0.51% | 0.00% |
| Nov. 13, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | S | Class A Common Stock | 1565 | $49.59 | 307,972.0000 | 0 | 0.51% | 0.00% |
| Nov. 13, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | M | Class A Common Stock | 310 | $2.90 | 308,282.0000 | 0 | 0.10% | 0.00% |
| Nov. 13, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | S | Class A Common Stock | 310 | $50.35 | 307,972.0000 | 0 | 0.10% | 0.00% |
| Nov. 13, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | M | Class A Common Stock | 1875 | $2.90 | 309,847.0000 | 0 | 0.61% | 0.00% |
| Nov. 13, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | S | Class A Common Stock | 1875 | $49.57 | 307,972.0000 | 0 | 0.61% | 0.00% |
| Nov. 13, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | M | Class A Common Stock | 1875 | $2.90 | 309,847.0000 | 0 | 0.61% | 0.00% |
| Nov. 13, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | S | Class A Common Stock | 1875 | $49.52 | 307,972.0000 | 0 | 0.61% | 0.00% |
| Nov. 13, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | M | Class A Common Stock | 1875 | $2.90 | 309,847.0000 | 0 | 0.61% | 0.00% |
| Nov. 13, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | S | Class A Common Stock | 1875 | $49.50 | 307,972.0000 | 0 | 0.61% | 0.00% |
| Nov. 13, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | M | Class A Common Stock | 7500 | $2.90 | 315,472.0000 | 0 | 2.44% | 0.00% |
| Nov. 13, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | S | Class A Common Stock | 7500 | $49.00 | 307,972.0000 | 0 | 2.38% | 0.00% |
| Nov. 13, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | M | Stock Option (Right to Buy) | 15625 | $0.00 | 753,587.0000 | 0 | 2.03% | 0.00% |
| Nov. 13, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | M | Stock Option (Right to Buy) | 1875 | $0.00 | 751,712.0000 | 0 | 0.25% | 0.00% |
| Nov. 13, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | M | Stock Option (Right to Buy) | 1875 | $0.00 | 749,837.0000 | 0 | 0.25% | 0.00% |
| Nov. 13, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | M | Stock Option (Right to Buy) | 1875 | $0.00 | 747,962.0000 | 0 | 0.25% | 0.00% |
| Nov. 13, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | M | Stock Option (Right to Buy) | 1875 | $0.00 | 746,087.0000 | 0 | 0.25% | 0.00% |
| Nov. 13, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | M | Stock Option (Right to Buy) | 7500 | $0.00 | 738,587.0000 | 0 | 1.01% | 0.00% |
| Oct. 23, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | S | Class A Common Stock | 600 | $41.61 | 307,972.0000 | 0 | 0.19% | 0.00% |
| Oct. 23, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | M | Class A Common Stock | 3750 | $2.90 | 311,722.0000 | 0 | 1.22% | 0.00% |
| Oct. 23, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | S | Class A Common Stock | 3750 | $42.00 | 307,972.0000 | 0 | 1.20% | 0.00% |
| Oct. 23, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | M | Stock Option (Right to Buy) | 15625 | $0.00 | 772,962.0000 | 0 | 1.98% | 0.00% |
| Oct. 23, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | M | Stock Option (Right to Buy) | 1875 | $0.00 | 771,087.0000 | 0 | 0.24% | 0.00% |
| Oct. 23, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | M | Stock Option (Right to Buy) | 1875 | $0.00 | 769,212.0000 | 0 | 0.24% | 0.00% |
| Oct. 23, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | S | Class A Common Stock | 2310 | $40.70 | 307,972.0000 | 0 | 0.74% | 0.00% |
| Oct. 23, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | M | Class A Common Stock | 600 | $2.90 | 308,572.0000 | 0 | 0.19% | 0.00% |
| Oct. 23, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | M | Class A Common Stock | 12715 | $2.90 | 320,687.0000 | 0 | 4.13% | 0.00% |
| Oct. 23, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | S | Class A Common Stock | 12715 | $39.81 | 307,972.0000 | 0 | 3.96% | 0.00% |
| Oct. 23, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | M | Class A Common Stock | 2310 | $2.90 | 310,282.0000 | 0 | 0.75% | 0.00% |
| Oct. 9, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | M | Class A Common Stock | 12273 | $2.90 | 320,245.0000 | 0 | 3.99% | 0.00% |
| Oct. 9, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | S | Class A Common Stock | 12273 | $38.08 | 307,972.0000 | 0 | 3.83% | 0.00% |
| Oct. 9, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | M | Class A Common Stock | 3352 | $2.90 | 311,324.0000 | 0 | 1.09% | 0.00% |
| Oct. 9, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | S | Class A Common Stock | 3352 | $38.83 | 307,972.0000 | 0 | 1.08% | 0.00% |
| Oct. 9, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | M | Stock Option (Right to Buy) | 15625 | $0.00 | 788,587.0000 | 0 | 1.94% | 0.00% |
| Sept. 25, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | M | Class A Common Stock | 900 | $2.90 | 308,872.0000 | 0 | 0.29% | 0.00% |
| Sept. 25, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | S | Class A Common Stock | 900 | $46.79 | 307,972.0000 | 0 | 0.29% | 0.00% |
| Sept. 25, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | M | Class A Common Stock | 975 | $2.90 | 308,947.0000 | 0 | 0.32% | 0.00% |
| Sept. 25, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | S | Class A Common Stock | 975 | $45.44 | 307,972.0000 | 0 | 0.32% | 0.00% |
| Sept. 25, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | M | Class A Common Stock | 900 | $2.90 | 308,872.0000 | 0 | 0.29% | 0.00% |
| Sept. 25, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | S | Class A Common Stock | 900 | $46.79 | 307,972.0000 | 0 | 0.29% | 0.00% |
| Sept. 25, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | M | Stock Option (Right to Buy) | 15625 | $0.00 | 811,712.0000 | 0 | 1.89% | 0.00% |
| Sept. 25, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | M | Stock Option (Right to Buy) | 1875 | $0.00 | 809,837.0000 | 0 | 0.23% | 0.00% |
| Sept. 25, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | M | Stock Option (Right to Buy) | 1875 | $0.00 | 807,962.0000 | 0 | 0.23% | 0.00% |
| Sept. 25, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | M | Stock Option (Right to Buy) | 1875 | $0.00 | 806,087.0000 | 0 | 0.23% | 0.00% |
| Sept. 25, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | M | Stock Option (Right to Buy) | 1875 | $0.00 | 804,212.0000 | 0 | 0.23% | 0.00% |
| Sept. 25, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | M | Class A Common Stock | 900 | $2.90 | 308,872.0000 | 0 | 0.29% | 0.00% |
| Sept. 25, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | M | Class A Common Stock | 8643 | $2.90 | 316,615.0000 | 0 | 2.81% | 0.00% |
| Sept. 25, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | S | Class A Common Stock | 8643 | $45.43 | 307,972.0000 | 0 | 2.73% | 0.00% |
| Sept. 25, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | M | Class A Common Stock | 4817 | $2.90 | 312,789.0000 | 0 | 1.56% | 0.00% |
| Sept. 25, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | S | Class A Common Stock | 4817 | $46.62 | 307,972.0000 | 0 | 1.54% | 0.00% |
| Sept. 25, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | M | Class A Common Stock | 2165 | $2.90 | 310,137.0000 | 0 | 0.70% | 0.00% |
| Sept. 25, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | S | Class A Common Stock | 2165 | $47.06 | 307,972.0000 | 0 | 0.70% | 0.00% |
| Sept. 25, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | M | Class A Common Stock | 975 | $2.90 | 308,947.0000 | 0 | 0.32% | 0.00% |
| Sept. 25, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | S | Class A Common Stock | 975 | $45.48 | 307,972.0000 | 0 | 0.32% | 0.00% |
| Sept. 25, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | M | Class A Common Stock | 900 | $2.90 | 308,872.0000 | 0 | 0.29% | 0.00% |
| Sept. 25, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | S | Class A Common Stock | 900 | $46.79 | 307,972.0000 | 0 | 0.29% | 0.00% |
| Sept. 25, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | M | Class A Common Stock | 975 | $2.90 | 308,947.0000 | 0 | 0.32% | 0.00% |
| Sept. 25, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | S | Class A Common Stock | 975 | $45.43 | 307,972.0000 | 0 | 0.32% | 0.00% |
| Sept. 25, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | S | Class A Common Stock | 900 | $46.79 | 307,972.0000 | 0 | 0.29% | 0.00% |
| Sept. 25, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | M | Class A Common Stock | 975 | $2.90 | 308,947.0000 | 0 | 0.32% | 0.00% |
| Sept. 25, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | S | Class A Common Stock | 975 | $45.48 | 307,972.0000 | 0 | 0.32% | 0.00% |
| Sept. 11, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | S | Class A Common Stock | 6351 | $37.78 | 307,972.0000 | 0 | 2.02% | 0.00% |
| Sept. 11, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | M | Stock Option (Right to Buy) | 15625 | $0.00 | 827,337.0000 | 0 | 1.85% | 0.00% |
| Sept. 11, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | M | Class A Common Stock | 6351 | $2.90 | 314,323.0000 | 0 | 2.06% | 0.00% |
| Sept. 11, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | S | Class A Common Stock | 9274 | $37.31 | 307,972.0000 | 0 | 2.92% | 0.00% |
| Sept. 11, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | M | Class A Common Stock | 9274 | $2.90 | 317,246.0000 | 0 | 3.01% | 0.00% |
| Aug. 28, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | S | Class A Common Stock | 700 | $37.54 | 322,667.0000 | 0 | 0.22% | 0.00% |
| Aug. 28, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | S | Class A Common Stock | 13995 | $36.82 | 308,672.0000 | 0 | 4.34% | 0.00% |
| Aug. 28, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | S | Class A Common Stock | 700 | $37.53 | 307,972.0000 | 0 | 0.23% | 0.00% |
| Aug. 28, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | M | Stock Option (Right to Buy) | 15625 | $0.00 | 842,962.0000 | 0 | 1.82% | 0.00% |
| Aug. 28, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | M | Class A Common Stock | 14925 | $2.90 | 337,592.0000 | 0 | 4.63% | 0.00% |
| Aug. 28, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | S | Class A Common Stock | 14925 | $36.80 | 322,667.0000 | 0 | 4.42% | 0.00% |
| Aug. 28, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | M | Class A Common Stock | 700 | $2.90 | 323,367.0000 | 0 | 0.22% | 0.00% |
| Aug. 21, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | S | Class A Common Stock | 14471 | $39.76 | 322,667.0000 | 0 | 4.29% | 0.00% |
| Aug. 14, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | M | Stock Option (Right to Buy) | 15625 | $0.00 | 858,587.0000 | 0 | 1.79% | 0.00% |
| Aug. 14, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | M | Class A Common Stock | 15625 | $2.90 | 352,763.0000 | 0 | 4.63% | 0.00% |
| Aug. 14, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | S | Class A Common Stock | 15625 | $37.56 | 337,138.0000 | 0 | 4.43% | 0.00% |
| Jan. 16, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | A | Stock Option (right to buy) | 292500 | $0.00 | 292,500.0000 | 0 | 9999.99% | 0.00% |
| Jan. 16, 2024 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | PRESIDENT AND CEO | A | Class A Common Stock | 78750 | $0.00 | 335,627.0000 | 0 | 30.66% | 0.00% |
| Dec. 29, 2023 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | President and CEO | M | Stock Option (Right to Buy) | 13000 | $0.00 | 874,212.0000 | 0 | 1.47% | 0.00% |
| Dec. 29, 2023 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | President and CEO | M | Class A Common Stock | 13000 | $2.90 | 256,877.0000 | 0 | 5.33% | 0.00% |
| Dec. 29, 2023 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | President and CEO | M | Stock Option (Right to Buy) | 516 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Dec. 29, 2023 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | President and CEO | M | Class A Common Stock | 516 | $2.32 | 243,877.0000 | 0 | 0.21% | 0.00% |
| Aug. 21, 2023 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | President and CEO | S | Class A Common Stock | 5210 | $16.66 | 243,361.0000 | 0 | 2.10% | 0.00% |
| Feb. 15, 2023 | Vera Therapeutics, Inc. | $VERA | Fordyce Marshall | President and CEO | A | Stock Option (right to buy) | 450000 | $0.00 | 450,000.0000 | 0 | 9999.99% | 0.00% |